Based on a CEA-controlled oncolytic adenovirus (CD55), Xiao et al. constructed a novel oncolytic adenovirus that harbors the Smad4 gene, named CD55-Smad4, and tested the potent antitumor efficacy of CD55-Smad4 in CRC. The gene discussed is CD55; the disease is colorectal carcinoma.